BlaiseAI

Developer of an artificial intelligence-enabled platform designed to advance synthetic lethal oncology. The company's platform identifies novel synthetic lethal targets and biomarkers and develops small-molecule therapeutic drug candidates, enabling clients to discover and develop treatments for cancer.

London, United KingdomStartup

Visit BlaiseAI

Partnerships

Clients

Team

Founded

2017

Employees

Featured companies:

Similar to BlaiseAI

View all companies

E1011 Labs

On a mission to bring the next generation of selfcare and personal wellness with innovative technology and thoughtfully-crafted formulations

Los Angeles, United States

Developer of an artificial intelligence-based healthcare technology designed to assist clinicians in detecting and diagnosing cancer. The company's technology develops imaging and multi-omics biomarkers and reporting tools using artificial intelligence and MRI, to support cancer screening and diagnosis, enabling clinicians and physicians to make cancer detection accurate, accessible, cost-effective, and quick.

Cambridge, United Kingdom